UC Named Lead Organization for OSHA Training Consortium
UC Continuing Medical Education (CME) has been selected as the lead organization for the Occupational Safety and Health Administration (OSHA) Great Lakes Training Consortium by the U.S. Department of Labor. OSHA also added 20 new training centers throughout the country and reconfigured regional consortia.
In addition to UC, the consortium includes the University of Minnesota, Eastern Michigan University, and the United Auto Workers Health & Safety Department.
The UC College of Medicine has been offering health and safety short courses for over 50 years and has been home to a National Institute for Occupational Safety and Health (NIOSH)-supported Education and Research Center (ERC) for 22 years.
Training is key to safety and health, said OSHA Administrator John Henshaw. The more employers and employees know about hazards and protection, the more injuries, illnesses and fatalities can be prevented. Expanding our education centers allows us to reach more people with information that can protect their safety and save their lives.
The 20 new centers will complement the OSHA Training Institute, the agencys primary training center in Illinois. The centers are responsible for training private sector personnel and federal personnel from agencies outside OSHA.
Centers were chosen based on occupational safety and health experience, non-academic training background, classroom and laboratory availability, and the ability to provide training throughout the region. OSHA provides no funding to the education centers, which offer training through their normal tuition and fee structures.
OSHAs Training Institute Education Center program was created in 1992. For further information or a complete list of all OSHA training centers throughout the country, visit
.
Related Stories
Study: Additional radiation for liver cancer does not increase toxicity
March 10, 2026
New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.
Phase 1 trial tests probiotic treatment for radiation side effects in the gut
March 9, 2026
The University of Cincinnati Cancer Center’s Bailey Nelson, MD, has been awarded a $50,000 pilot grant from the Cancer Center to open a Phase 1 trial testing if a probiotic supplement can reduce gastrointestinal symptoms for patients undergoing whole pelvis radiotherapy.
Is uACR the key to cardiovascular and kidney disease prevention?
March 8, 2026
As a precision biomarker, the urinary albumin-to-creatinine ratio (uACR) can guide physicians toward personalized, patient-centered prevention and treatment of both cardiovascular disease (CVD) and chronic kidney disease (CKD), according to new data published in the Journal of Internal Medicine.